T he trimeric protein cardiac troponin (cTn) is associated with the sarcomeric thin filament and is a key protein that regulates cardiac contraction. Calcium binds to cTn causing a conformational shift in tropomyosin and allowing actin and myosin to form a force generating cross-bridge. cTn is more than a simple on-off switch for contraction; it can exert more complex control through its phosphorylation. For example, the inhibitor subunit of cTn, cTnI, has shown significant modulatory capacity when phosphorylated by protein kinase (PK)A and PKC. Some of these aspects of control include filament sliding speed, 1 calcium sensitivity, 2 cross-bridge cycling, 3 and MgATPase activity. 4 These affect global force production and relaxation responses to afterload, 5 frequency 5 and length. 6 There are at least five phosphorylatable sites on cTnI: serines at 23, 24, 43 and 45 (S23, S24, S43, S45) and a threonine at 144 (T144). The sites nearest the N-terminal (S23, S24) are primarily phosphorylated by PKA, whereas the other 3 sites (S43, S45, T144) are primarily phosphorylated by PKC. There may be other phosphorylation sites, including S150 7 and S76/T77 8 (in human) as well as other kinases that act on cTnI, including p21-activated kinase 7 and Mst1 (mammalian sterile 20-like kinase 1). 9 In the present study, we have focused on PKC phosphorylation for 2 reasons: (1) PKC is upregulated during heart failure 10, 11 ; and (2) its effects are largely dominant over those of PKA. 4 We previously created a transgenic (TG) mouse with mutated PKC phosphorylation sites on cTnI: S43 and S45 were replaced with alanines to mimic nonphosphorylatable sites (cTnI S43/S45-NP ). Decreased phosphorylation at these sites causes a positive inotropic response, 12, 13 no change in relaxation 13 or calcium sensitivity, 14 increased MgATPase activity, 14 and increased susceptibility to ischemic contracture. 15 The cTnI S43/S45-NP mouse also rescued cardiac function when it was crossed with a heart failure model (PKC overexpression mutation). 16 To study increased PKC phosphorylation of cTnI, we created a new TG mouse model (cTnI PKC-P ) wherein S43, S45, and T144 on cTnI were replaced with glutamic acids to simulate constitutive phosphorylation. Note this new model mutated the threonine at position 144, which the cTnI S43/S45-NP mouse did not. Authentic phosphorylation of these 3 sites by PKC produced responses that closely mimic the effect of pseudophosphorylation using glutamic acid in reconstituted fibers. 1 Based on previous work with the cTnI S43/S45-NP mouse, we hypothesized that the cTnI PKC-P mouse will exhibit negative inotropy and unchanged relaxation. Our goal was to test this hypothesis and determine how activator calcium, myofilament activation, and myofilament contraction contribute to the observed functional effects.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Serine 43 and 45 and threonine 144 residues on cTnI were replaced with glutamic acid to simulate constitutive phosphorylation.
Steps to create the TG mouse were similar to the creation of the cTnI S43/S45-NP mouse and have been described elsewhere. 15 Here, we refer to this mouse as cTnI PKC-P , or the TG mouse. Two-dimensional difference in gel electrophoresis (2D-DIGE) was used to determine percentage replacement of endogenous cTnI with mutant cTnI in the cTnI PKC-P mice, changes in the posttranslational modifications of cTnI (primarily phosphorylation), and other myofilament proteins.
The mice were anesthetized with an intraperitoneal injection of Avertin (2,2,2-tribromoethanol, 250 mg/kg body weight), and hearts were quickly excised. Left ventricular (LV) pressure was measured in isolated heart preparations 17 ; wall stress () was estimated using Online Equation A2.1. 18 Force and intracellular calcium transients ([Ca] i ) were measured simultaneously 19 in intact posterior right ventricular papillary muscles. Isometric force and ATPase activity were measured simultaneously 20 in skinned LV papillary muscle strips (sarcomere length set at 2.2 m).
For the isolated heart and papillary muscle data, regression analysis with dummy variables was used to identify differences in various relationships between wild-type (WT) and TG groups. Student's t tests were used to compare all other data. Data are expressed as meansϮSEM.
Results

Characterization of the Mouse Model
The cTnI PKC-P mice showed no differences in body mass (WT: 30.7Ϯ1.6 g; cTnI PKC-P : 31.3Ϯ1.0 g), LV mass (WT: 102.4Ϯ6.7 mg; cTnI PKC-P : 103.7Ϯ4.2 mg), or their ratio (WT: 296Ϯ9; cTnI PKC-P : 303Ϯ9). There were also no overt signs of heart failure, including lethargy or differences in feeding.
Two-Dimensional Difference in Gel Electrophoresis Analysis
Proteins from WT and cTnI PKC-P myofibrils were separated using 2D-DIGE ( Figure 1A ). The 2D-DIGE gels were capable of separating cTnI species with posttranslational modifications and unmodified species (U: unmodified cTnI; Px: posttranslational modified cTnI, where xϭnumber of possible modifications). In cTnI PKC-P samples, there was an additional spot near P3, indicated by an asterisk in Figure 1A , which was not present in the WT samples. We postulated this spot represented mutant cTnI.
To confirm this spot was constitutively pseudophosphorylated mutant cTnI, we treated WT and cTnI PKC-P myofibrils with PP1A and PP2A 1 to dephosphorylate cTnI ( Figure 1B) . The WT cTnI spot profile was reduced to the U (unmodified) spot, indicating: (1) that phosphorylation was the primary posttranslational modification, (2) complete dephosphorylation, and (3) that at least 1 phosphorylation site was associated with each Px spot. In the phosphatase-treated cTnI PKC-P samples, there were 2 spots: U and mutant cTnI (indicated by an asterisk in Figure 1B ). The ratio of the intensity of the mutant cTnI spot to the total intensity (ie, sum of unmodified spot [U] and mutant spot) represents the percentage replacement, which was 7.2Ϯ0.5% (nϭ9) (Online Table I ).
To verify the protein identity of the spots, membrane transfers of the 2D-DIGE gels were probed with a specific pan cTnI antibody. Figure 1C illustrates multiple spots in the untreated samples, whereas only one spot is visible in the phosphatasetreated sample, a pattern similar to that in the 2D-DIGE gels ( Figure 1A and 1B, second images). All 6 spots are identified in the Online Figure IB . The mutant cTnI spot was also confirmed by Western analysis (Online Figure IA) .
There were no differences in the relative spot intensities (U, P1-P5) of cTnI in the WT and cTnI PKC-P samples, except the presence of the mutant cTnI spot ( Figure 1A and Online Table I ). This indicates that the basal pattern of actual phosphorylation of cTnI was unchanged in the TG mouse. Moreover, there were no differences in the phosphorylation levels of cTnT, tropomyosin, myosin regulatory light chain, or myosin binding protein C ( Figure 1D and Online Table I ; n: WTϭ4, cTnI PKC-P ϭ4).
Isolated Heart Experiments
LV pressure waveforms are shown for the Frank-Starling protocol for an individual WT ( Figure 2A ) and cTnI PKC-P ( Figure 2B ) animal over the same range of chamber volumes (12 L V max ). For a better visual comparison, the pressure waveforms from WT and cTnI PKC-P for a single chamber volume (V max ) are shown superimposed, both as absolute values ( Figure 2C , top) and normalized values ( Figure 2C , bottom). Group averaged P dev and P ed values over the entire range of chamber volumes are illustrated in Figure 2D .
The cTnI PKC-P mice exhibited reduced systolic function. The slope of the dev -volume relationship was reduced in cTnI PKC-P mice (WT: 2.9Ϯ0.1 mm Hg ⅐ L Ϫ1 , nϭ6, cTnI PKC-P : 2.5Ϯ0.1 mm Hg ⅐ L Ϫ1 , nϭ6, Pϭ0.02), with no change in the intercept, indicating a 14% reduction in LV contractile state over all lengths ( Figure 3A) . Additionally, there was a decrease in the slope of the d/dt max -volume relationship (WT: 0.084Ϯ0.004 mm Hg ⅐ ms Ϫ1 ⅐ L Ϫ1 , nϭ6; cTnI PKC-P : 0.074Ϯ0.003 mm Hg ⅐ ms Ϫ1 ⅐ L Ϫ1 , nϭ6, Pϭ0.03), with no change in the intercept, indicating a 12% decrease in the kinetic aspects of contraction ( Figure 3B ).
The cTnI PKC-P mice exhibited slowed relaxation as evidenced by a parallel, upward shift of the T relax -volume relationship (intercept values: WT: 16Ϯ1 ms, nϭ6; cTnI PKC-P : 21Ϯ3 ms, nϭ6, Pϭ0.005), with no change in the slope, indicating a 20% increase (maximum) in the time for the LV to relax ( Figure 3C ). Consistent with this observation, there was a decrease in the magnitude of the slope of the d/dt min -volume relationship (WT: Ϫ0.067Ϯ0.003 mm Hg ⅐ ms Ϫ1 ⅐ L
Ϫ1
, nϭ6; cTnI PKC-P :
, nϭ6, Pϭ0.03), with no change in the intercept, indicating a 16% reduction in the kinetic aspects of relaxation ( Figure 3D ).
The cTnI PKC-P mice showed no differences in passive properties compared to WT mice. There were no statistical differences in P ed ( Figure 2D , triangles) or ed (Online Figure  II) over the entire range of volumes studied.
Treatment with 1 mol/L isoproterenol increased developed pressures to the same degree in both WT and cTnI PKC-P (Table 1) . Isoproterenol also shortened rise and relaxation times to the same degree in WT and cTnI PKC-P animals ( Table 1) . Figure 4A shows representative force and calcium data from one WT and one cTnI PKC-P experiment. The cTnI PKC-P mice exhibited decreased force production, indicated by a downward shift of the developed force (F dev Figure 4B ). There was also slowed relaxation in the cTnI PKC-P mice, as evidenced by an Figure 4C ). In contrast, intracellular calcium concentration transients ([Ca] i ) were unaltered in cTnI PKC-P mice, exhibiting no changes in the slope or intercept of the [Ca] i amplitude (as quantified by R sys /R ed )-length relationship (probability value: for slopeϭ0.53, for interceptϭ0.83, Figure 4D ), or the relaxation (as quantified by dR/dt min )-length relationship (Pϭ0.23 for slope, Pϭ0.28 for intercept, Figure 4C ).
Isolated Papillary Muscle Experiments
Skinned Fiber Experiments
There was a 14% decrease (n: WT, 10 fibers from 4 mice; cTnI PKC-P , 10 fibers from 3 mice) in maximally activated force (F max ) in the cTnI PKC-P mice ( Figure 5A and Table 2 ). Although there was a similar decrease (9%) in maximal MgATPase activity ( Figure 5C and Table 2 ), it was not statistically significant. The skinned fiber data were fit to the modified Hill equation (Online Equation A4.1). There were no differences in pCa 50 (calcium sensitivity) or Hill coefficient (n H , cooperativity) for either the pCa-force ( Figure 5B and Table 2 ) or pCa-MgATPase ( Figure 5D ) relationships. The force-MgATPase activity relationship was linear ( Figure  5E ), and its slope is defined as the tension cost. There were no differences in the tension cost between the WT (7.33Ϯ0.13, R 2 ϭ0.97) and cTnI PKC-P (7.41Ϯ0.10, R 2 ϭ0.98) mice (Table 2) .
Discussion
We created a new TG mouse model (cTnI PKC-P ) wherein the 3 PKC phosphorylation sites on cTnI were mutated to glutamic acid to simulate constitutive pseudophosphorylation. Despite low integration of mutant protein (Ϸ7%), TG mice show significant functional changes, indicating high sensitivity of cardiac contraction to PKC cTnI phosphorylation. There are 3 main experimental findings of the present study. Compared to WT mice, cTnI PKC-P mice exhibited: (1) decreased active contraction and slowed relaxation, (2) a preserved response to ␤-adrenergic stimulation, and (3) decreased maximally activated force without changes in calcium sensitivity or tension cost. We discuss each of these observations individually below, followed by an integrative interpretation that reconciles these experimental findings. Values are meansϮSEM. P dev indicates developed pressure; T rise , rise time; T relax , relaxation time. There were no differences in the response to isoproterenol treatment between the WT and TG mice at V max (volume that produced maximum P dev ).
TG Mouse Model
The cTnI PKC-P mouse showed Ϸ7% replacement of endogenous cTnI with mutant cTnI. There were no differences in the basal actual phosphorylation pattern of cTnI. Therefore, there is an increase in total phosphorylation of cTnI at the PKC sites: the summation of basal actual phosphorylation (unchanged in cTnI PKC-P mice) and pseudophosphorylation (increased by Ϸ7% in cTnI PKC-P mice). In spite of the relatively low level of replacement, there were significant functional effects. This is an unexpected and remarkable finding, suggesting a high sensitivity of cardiac contraction to PKCmediated cTnI phosphorylation and potentially important physiological and pathophysiologic roles for this posttranslational regulatory process.
Recent evidence indicates that basal in vivo cTnI phosphorylation at the PKC sites is very low. 8, 21 Thus, the percentage replacement in our TG mice, although small, may represent a physiologically relevant level of increased PKC cTnI phosphorylation. Our previous mouse model, cTnI S43/S45-NP (serine 43 and 45 mutated to alanine), showed Ϸ50% replacement of endogenous cTnI by the mutant cTnI. 14 However, given the low basal phosphorylation state, a higher replacement of nonphosphorylatable sites would be required to observe functional effects.
There were also no alterations in phosphorylation of tropomyosin, TnT, essential light chain, or myosin binding protein-C, indicating that the observed effects were from cTnI PKC pseudophosphorylation alone.
Contraction
There was evidence of reduced contraction in the cTnI PKC-P mice compared to WT mice at all 3 levels studied: (1) isolated ) and normalized to the end diastolic value of R (R ed ). A, Representative force (top) and calcium (bottom) data for WT (solid line) and cTnI PKC-P (dashed line) mice at 3 lengths (100%, 96%, and 92% of L max ). Effects of altered muscle length on developed force (F dev ) (B), dF/dt min (relaxation) (C), R sys (peak systolic R) normalized by R ed (end diastolic R) (D), and dR/dt min (calcium relaxation) (E) in WT (closed circles) and cTnI PKC-P (open circles) mice. The raw data were fitted to a linear trend line (WT: solid line; TG: dashed line). Compared to the WT data, the intercept of the F dev -length relationship was significantly lower (PϽ0.05) and the intercept of the dF/dt min -length relationship was significantly higher (PϽ0.05) in the cTnI PKC-P mice. There were no differences in the intercept or slope of the R sys /R ed -length or dR/dt min -length relationships. showing WT mice have significantly higher F max than cTnI PKC-P mice. B, Relative force data (%F max ) showing no differences in pCa 50 (calcium sensitivity) or Hill coefficient (cooperativity) between the WT and cTnI PKC-P mice. C, Absolute MgATPase activity (pmol ⅐ mm Ϫ3 ⅐ sec Ϫ1 ) shows WT mice have a higher, but not statistically significant, maximal value. D, Relative MgATPase activity (%Max) shows no differences in pCa 50 or n H values. E, There was no difference in the slope of the fitted linear regression, representing tension cost, between the 2 groups.
heart experiments showed depressed developed pressures, (2) intact papillary muscles exhibited lower developed force, and (3) skinned fibers showed significantly lower F max . In reconstituted fibers where the cTnI PKC phosphorylation sites were rendered constitutively pseudophosphorylated, a decrease in F max was also seen. 1 The cTnI S43/S45-NP mouse model showed an increase in developed pressures at high extracellular calcium levels (3.5 mmol/L [Ca]). 13 Together with previous data, the new TG model supports the hypothesis that phosphorylation of cTnI by PKC lowers the ability of the myocardium to generate active force, both under dynamic and steady-state activations.
Relaxation
In isolated heart and intact papillary muscle experiments, cTnI PKC-P mice also showed negative lusitropy when compared to control mice. This is consistent with the results of Pi et al, who treated WT mice with the PKC activator endothelin-1 and observed an increase in relaxation time (negative lusitropy). 22 Furthermore, in their TG animal, in which all 5 cTnI phosphorylation sites were replaced with alanines, the effects of endothelin-1 were severely blunted. These results, combined with the results presented here, suggest that phosphorylation of the PKC sites on cTnI has a negative lusitropic effect. By that same logic, the cTnI S43/S45-NP mouse would be expected to exhibit positive lusitropy, but it did not. 13 However, in the cTnI S43/S45-NP mouse, the T144 is not mutated to an nonphosphorylatable alanine. Thus, phosphorylation of T144 on cTnI may be primarily responsible for PKC-induced slowing of relaxation.
Response to ␤-Adrenergic Stimulation
The cTnI PKC-P and WT mice responded similarly to isoproterenol (1 mol/L) infusion: increasing developed pressure and decreasing rise and relaxation times. ␤-Adrenergic stimulation acts through PKA-activated pathways, specifically the phosphorylation of PKA sites on cTnI (S23 and S24) and cellular calcium-handling proteins (eg, sarcoplasmic reticulum ATPase pump, L-type calcium channels). These results show that the mutation we introduced in cTnI did not affect these PKA-dependent pathways.
Intracellular Calcium Transients
There were no differences in intracellular calcium amplitude or relaxation between WT and cTnI PKC-P mice. We have previously reported that cTnI S43/S45-NP mice do not exhibit any differences in intracellular calcium at normal extracellular calcium levels. 15 Others have also shown that there are no changes in intracellular calcium with PKC phosphorylation of cTnI. 22, 23 Normalized fluorescence values (R/R ed or R sys /R ed ), instead of calibrated data, were used in analyzing calcium transients. The reasons for using this approach and its validity are discussed in Online Appendix 3.
Calcium Sensitivity
cTnI PKC-P mice did not exhibit differences in calcium sensitivity compared to WT mice. Burkart et al conducted experiments on detergent-extracted cardiac fibers reconstituted with 3 forms of mutant cTnI that were pseudo phosphorylated at the PKC sites: S43E/S45E, S43E/S45E/T144E, and T144E. 1 They showed that S43E/S45E and S43E/S45E/ T144E fibers exhibited similar decreases in calcium sensitivity. However, there was no change in calcium sensitivity in T144E fibers, suggesting that phosphorylation at this site plays no role. This is inconsistent with data from Wang et al in which chemical phosphorylation of T144 by PKC-␤⌱⌱ resulted in increased calcium sensitivity. 24 The reconstituted fibers studied by Burkart et al showed a much higher replacement of endogenous cTnI with the mutant form (70% to 97%) than was present in our cTnI PKC-P mouse, although it is unclear whether it is appropriate to directly compare the extent of replacement in the TG mouse and reconstituted system. Wang et al found that PKC-␤⌱⌱ caused a 20% to 50% incorporation of radiolabeled phosphate, which was much closer to the level of phosphorylation simulated by our mutant cTnI. This suggests calcium sensitivity may be affected differently at very high, possibly nonphysiologic, levels of PKC phosphorylation of cTnI.
Because our model simulates phosphorylation at all 3 PKC sites, it is possible there are 2 offsetting effects on calcium sensitivity: a decrease in calcium sensitivity attributable to the (pseudo)phosphorylation at S43/S45 and an increase in calcium sensitivity in response to the (pseudo)phosphorylation at T144. If PKC phosphorylates all 3 positions, what is the purpose of mutually offsetting effects at the different sites? One possibility is that certain PKC isoforms only phosphorylate or preferentially phosphorylate a given residue, resulting in unequal phosphorylation on the 3 sites. For example, PKC-␤⌱⌱ 24 and tyrosine-phosphorylated PKC␦ 25 preferentially phosphorylate T144.
Integrative Interpretation
Our goal was to identify the underlying changes in myofilamental processes that can simultaneously explain all of our results. We can group the contraction/relaxation processes into 3 main categories: (1) activator calcium, (2) myofilament activation, and (3) myofilament contraction.
There were no differences in intracellular calcium transients in the WT and cTnI PKC-P mice (Figure 4 ). This suggests there are no differences in the activator calcium.
The slope of the force-MgATPase activity relationship is the tension cost and represents an estimate of the cross-bridge detachment rate constant (g). 26 , 27 The cTnI PKC-P mice exhibited no change in tension cost compared to WT mice, 
Kirk et al PKC Phosphorylation of Cardiac Troponin I
implying unaltered g. Because the decrease in F max cannot be attributed to calcium activation or cross-bridge detachment, it is most likely attributable to a decrease in cross-bridge formation rate constant (f).
We used a mathematical model ( Figure 6B ) to interpret experimental results and determine what myofilamental processes were altered in the cTnI PKC-P mouse (see Online Appendix 5). This model has been used for data analysis before. 17, 28, 29 Decreasing the value of f (23%) predicted the observed decrease in maximum twitch force and F max , but also showed decreased calcium sensitivity and no change in relaxation, contrary to our experimental observations. Therefore, there must be another altered process that slows relaxation. What parameter (or set of parameters), altered simultaneously with f, would produce decreased magnitude of contraction (both under twitching and steady-state conditions), increased relaxation time, and no change in calcium sensitivity or tension cost? We focused on parameters that would maintain the activation state ( Figure 6A ): (1) increased calcium binding (increased k 1 ) and (2) decreased cross-bridge dissolution in the absence of cTnC-bound calcium (decreased d). Although the first perturbation can produce slowed relaxation, it was unable to reconcile all of the experimental observations.
The second perturbation (a decrease in f by 23% and a decrease in d by 35%) reproduced the experimental observations (compare Figures 5E with 6B, 2C with 6C and 6D, 5A with 6E, and 5B with 6F). The magnitude of these changes closely mirrored the observations in the isolated heart (14% negative inotropy, 20% negative lusitropy) and skinned fiber (14% decrease in F max , less than 2% change in pCa 50 , n H , and tension cost). These magnitudes acted as a guide, the goal was not to identify exact parameter values, but identify a plausible solution which explained the major findings of our experiments. Our experimental data and the model-based analysis suggest that the TG mouse has 2 altered myofilament processes: decreased rate constant of cross-bridge formation and a calcium-independent persistence of the active state.
The model also indicated that an isolated decrease in d was associated with an increase in calcium sensitivity and slowed relaxation. Experimental data suggests T144 phosphorylation causes an increase in calcium sensitivity 24 and is primarily responsible for slowed relaxation. It is therefore tempting to attribute the calcium-independent persistence of myofilament active sate (ie, decreased d) to T144 phosphorylation. Likewise, the model indicated that an isolated decrease in f was associated with a decrease in calcium sensitivity, no change in relaxation, and negative inotropy. Experimental data suggest that phosphorylation of S43 and S45 results in decreased calcium sensitivity, 1 no change in relaxation, 13 and negative inotropy. 13 Thus, it is possible that the decrease in rate constant of cross-bridge formation (f) is a result of S43 and S45 phosphorylation. The precise biophysical mechanisms underlying the regulation of myofilament contractile properties by PKC-mediated phosphorylation of cTnI are not presently known.
Limitations
(1) Although the 2D-DIGE data clearly indicate unchanged overall pattern of actual phosphorylation of cTnI in TG mice ( Figure 1A and Online Table I ), we cannot definitely say that cTnI phosphorylation at PKA sites was unchanged. Additional data using mass spectrometry will be needed to quantify cTnI phosphorylation at individual sites. (2) Because a single TG mouse line was used in the present study (ie, a single level of transgene expression), it is not possible to determine how the observed effects scale with the level of cTnI phosphorylation at PKC sites. Additional TG mouse lines and/or experiments using reconstituted fibers will be necessary to address this issue. (3) Although it is a commonly used technique, pseudophosphorylation by glutamate replacement may not fully recapitulate actual phosphorylation. Furthermore, the simultaneous (pseudo)phosphorylation of all 3 PKC sites may or may not be a physiologically relevant pattern of cTnI phosphorylation. However, our TG mouse data, together with data from the literature, provide new insights into the effects of PKCmediated cTnI phosphorylation.
Summary
Our data show a small increase in cTnI phosphorylation at PKC sites produces significant functional changes, indicating high sensitivity of cardiac contraction to PKC-mediated cTnI phosphorylation. Model-based analysis predicts that these functional changes are brought about by specific changes in myofilament contractile properties: decreased rate of crossbridge formation and calcium-independent persistence of the active state. Based on our data and data from the literature, we speculate that the effects of PKC-mediated cTnI phosphorylation are site-specific (S43/S45 versus T144). 
SUPPLEMENTAL MATERIAL
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strips were equilibrated and laid onto 12% SDS-PAGE gels 4, 6 . Gels were imaged with a
11
Typhoon 9410 scanned at 100 µm and analyzed with PDQuest software (v7.1, BioRad,
12
Hercules, CA). PDQuest software analyzes the gel images by determining the optical densities 
16
group and compared using a T-test with a level of significance set at P-value < 0.05. Gels were 17 transferred on PVDF membrane and analyzed as previously described 7 . The primary antibody 18 used for cTnI was a pan monoclonal C5 1:5000 (Fitzgerald) and the secondary antibody was an 
5
Isolated heart preparations were similar to those we have done in the past 8 . Male WT FVB and 6 cTnI PKC-P mice of similar age (121 -140 days) were used. The mice were anesthetized with an 7 intraperitoneal injection of Avertin (2,2,2-tribromoethanol, 250 mg/kg body weight). Animals 8 were then anticoagulated using 100 units of heparin. Once the heart was excised from the 9 animal, the aorta was quickly cannulated. We then began retrograde aortic perfusion at a 
17
A catheter-tip pressure transducer (MPC-500, Millar Instruments, Houston, TX) was used to 18 measure left ventricular pressure. The balloon volume was altered using a thumb-screw 19 controlled 100 µL micro-syringe (Hamilton Gas Tight, Reno, NV). Platinum pacing electrodes 20 were placed on the heart, which was then paced at 4 Hz using a Harvard stimulator (Harvard
21
Apparatus, Holliston, MA). Pressure data were digitized on-line at 500 Hz for later offline to yield a LV end diastolic pressure of 5 mmHg. Pressure data were continuously recorded over a 2-min period. The first 20 seconds corresponded to data at the reference volume, followed by 1 a period wherein LV volume was increased in 2 µl increments to the point when developed 2 pressure had reached its maximum value (V max ). The Frank Starling protocol alone was 3 performed on one subset of experiments (wild-type, WT: n = 6, transgenic, cTnI PKC-P : n = 6).
4
In the second subset of the experiments (WT: n = 6, cTnI PKC-P : n = 6), the Frank Starling 5 protocol was performed, and then isolated hearts were treated with 1 μmol/L isoproterenol for 6 ten minutes. A second Frank-Starling protocol was conducted on the heart post isoproterenol 7 treatment.
8
Data Analysis. In isolated heart experiments, individual cardiac cycles were first 9 identified by using the spike in the pacer signal. Signal averaging over the cardiac cycle was 10 then performed to reduce high-frequency random noise. Pressure data from five to seven 11 steady state contractions at a given LV volume were averaged to yield a representative cycle.
12
LV pressure waveforms were characterized by several amplitude and rate indices. Amplitude
13
indices included end diastolic pressure (P ed ), peak systolic pressure (P sys ), and developed 14 pressure (P dev = P sys -P dia ). Rate indices included maximal rate of rise (dP/dt max ), maximal rate 15 of fall (dP/dt min ), rise time (T rise ), and relaxation time (T relax ). T relax was defined as the time taken
16
for developed pressure to decay from 75% to 25% of its maximum value. Similarly, T rise was 17 defined as the time taken for pressure to rise from 25% to 75% of its maximum value.
18
Calculations of T relax and T rise were performed after the diastolic value of the pressure waveform
19
was subtracted, such that each waveform rose from and declined to zero.
20
Wall stress (σ) was estimated using a thick-walled spherical model from equation A2. 
22
where P is pressure, M is the mass of the left ventricle, ρ is the density of muscle, which was 23 assumed to be 1.05 g/ml, and V is the volume of the ventricle. Equation A2.1 was used to calculate σ dev , σ ed , dσ/dt max , and dσ/dt min by using P dev , P ed , dP/dt max and dP/dt min in place of P, 1 respectively.
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Statistical Analysis. For the isolated heart data, regression analysis with dummy 3 variables was used to identify differences in various relationships between wild-type and 4 transgenic groups: σ dev -volume, dσ/dt max -volume, T relax -volume, dσ/dt min -volume. and muscle length (L max ) were adjusted to obtain maximum developed force. The muscle was 13 allowed to equilibrate for at least 30 minutes before performing the experimental protocol.
14
Muscle diameter was recorded using a digital video microscopy system (Ionoptix, Milton, MA),
15
and cross-sectional area (mm 2 ) was calculated assuming cylindrical geometry.
16
Calcium measurements using fura-5F required a system capable of dual excitation, 
10
Calcium Calibration. We did perform the standard calibration measurements after every 
6
Both the wild-type and the transgenic mice were anesthetized with pentobarbital sodium 7 (50 mg/kg body wt), and hearts were rapidly excised and immediately placed into ice-cold high 
13
Thin muscle fiber bundles (~200 μm in width and ~2.0 mm in length) were dissected and were 14 detergent skinned overnight using 1% TritonX-100 to chemically permeabilize the muscle fiber 
7
Isometric force and ATPase activity were simultaneously measured at 20°C as 8 described previously 13, 14 . Briefly, the force developed at steady-state was measured by the 9 force transducer and recorded using LabView software. where X is a measured quantity at a given pCa and X max is the maximally activated value (i.e. at 4 pCa = 4.33). Two parameters were estimated from normalized force-pCa data for each fiber:
5 pCa 50 (pCa required to produce normalized value of 50%) and the Hill coefficient (n H , a measure 6 of the steepness of the normalized force-pCa or MgATPase-pCa curve, which characterizes the 7 cooperative phenomena). 
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MODELING METHODS
2
The four-state model schematic is shown in Figure 6B , and the model is described by 
